Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Pt 1
pubmed:dateCreated
2004-3-22
pubmed:abstractText
Anandamide ( N-arachidonoylethanolamine) and other bioactive N-acylethanolamines are degraded to their corresponding fatty acids and ethanolamine. This hydrolysis is mostly attributed to catalysis by FAAH (fatty acid amide hydrolase), which exhibits an alkaline pH optimum. In addition, we have identified another amidase which catalyses the same reaction exclusively at acidic pH values [Ueda, Yamanaka and Yamamoto (2001) J. Biol. Chem. 276, 35552-35557]. In attempts to find selective inhibitors of this acid amidase, we screened various derivatives of palmitic acid, 1-hexadecanol, and 1-pentadecylamine with N-palmitoylethanolamine as substrate. Here we show that N-cyclohexanecarbonylpentadecylamine inhibits the acid amidase from rat lung with an IC50 of 4.5 microM, without inhibiting FAAH at concentrations up to 100 microM. The inhibition was reversible and non-competitive. This compound also inhibited the acid amidase in intact alveolar macrophages. With the aid of this inhibitor, it was revealed that rat basophilic leukaemia cells possess the acid amidase as well as FAAH. Thus the inhibitor may be a useful tool to distinguish the acid amidase from FAAH in various tissues and cells and to elucidate the physiological role of the enzyme.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-10431820, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-10521710, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-11106785, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-11106786, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-11106787, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-11309246, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-11345902, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-11463796, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-11470906, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-11585048, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-11700558, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-11945130, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-11945157, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-12010121, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-12052034, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-12052035, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-12052036, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-12052051, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-12065702, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-12505695, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-12505696, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-12655057, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-12736361, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-12955147, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-14521402, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-1470919, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-4055775, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-7827116, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-9013571, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-9065728, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-9070224, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-942051, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-9649760, http://linkedlifedata.com/resource/pubmed/commentcorrection/14686878-9685157
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1470-8728
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
379
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
99-106
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:14686878-Amides, pubmed-meshheading:14686878-Amidohydrolases, pubmed-meshheading:14686878-Animals, pubmed-meshheading:14686878-Cell Line, Tumor, pubmed-meshheading:14686878-Dose-Response Relationship, Drug, pubmed-meshheading:14686878-Enzyme Inhibitors, pubmed-meshheading:14686878-Hydrogen-Ion Concentration, pubmed-meshheading:14686878-Inhibitory Concentration 50, pubmed-meshheading:14686878-Leukemia, Basophilic, Acute, pubmed-meshheading:14686878-Liver, pubmed-meshheading:14686878-Lung, pubmed-meshheading:14686878-Macrophages, Alveolar, pubmed-meshheading:14686878-Neoplasm Proteins, pubmed-meshheading:14686878-Organ Specificity, pubmed-meshheading:14686878-Palmitic Acids, pubmed-meshheading:14686878-Rats, pubmed-meshheading:14686878-Rats, Wistar, pubmed-meshheading:14686878-Substrate Specificity
pubmed:year
2004
pubmed:articleTitle
N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.
pubmed:affiliation
Department of Biochemistry, Kagawa University School of Medicine, 1750-1 Ikenobe, Miki, Kagawa 761-0793, Japan.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't